Lactobacillus lactis Dorner (strain ATCC 8000) was used in these studies according to the procedure previously described (Caswell et al., 1949) . When E. gracilis was used, the medium and procedure were that of Hutner et al. (1949) . A modification of the medium described by Skeggs et al. (1948) was employed for L. leichmannii (strain ATCC 4797).
All experiments were conducted in 20 by 180 mm Pyrex test tubes containing a total volume of 5 ml unless otherwise specified. Sterilization was accomplished by autoclaving for 13 minutes at 120 C. Since in preliminary experiments with the dimethylbenzimidazole and the dimethyldiamine, no significant differences were noted between aseptic addition of previously sterilized compounds and their sterilization together with the medium, the latter procedure was used throughout.
The lactobacilli were incubated for 60 hours at 37 C, after which time growth was determined titrimetrically. E. gracilis was incubated in the light at 28 C for 6 days and growth determined turbidimetrically.
RESULTS AND DISCUSSION
In studying the inhibitory effect of the dimethyldiamine and the dimethylbenzimidazole, it was noted that much higher levels of the benzimidazole were DAVID HENDI.IN AND MARGARET H. SOARS required for half-maximal inhibition. The diamine appeared to be twice as effective as the benzimidazole in medium supplemented with half-maximal levels of vitamin B12 (0.04 mAg per ml). While the half-maximal inhibitory level of the benzimidazole was unchanged in medium containing 200 X the optimal level of vitamin B12, the amount of diamine required under similar conditions doubled. It appeared from these preliminary data that vitamin B12 decreased the toxicity of the diamine but had no significant effect on the benzimidazole toxicity.
A more detailed study of this neutralizing effect of vitamin B12 was undertaken. The results obtained ( figure 1) Figure 1 antagonizes the toxicity of the dimethyldiamine. This phenomenon is more pronounced in experiments in which 10 ml per tube total volume is used, because the requirement of the organism for vitamin B12 is decreased under these conditions (Koditschek, Hendlin, and Woodruff, 1949) so that the antagonism can be shown at lower levels of the vitamin. On the basis of half-maximal inhibition, the inhibition index inhibitor is approximately one million over a narrow \metabolite/ range of inhibitor. Beyond this range, the inhibition is irreversible with vitamin B12; and in this respect, it is similar to the inhibition noted with the benzimidazole.
Several substituted anilines were also investigated (table 1). It was noted that aniline, o-xylene, and o-phenylenediamine were nontoxic at levels as high as 1 mg per ml, while o-xylidine showed some toxicity at this level but nowhere near the toxicity of the dimethyldiamine. More than that, these compounds, while inactive in replacing vitamin B12 for the growth of L. lacti8, possessed vitamin B12 activity in the presence of minimal levels of the vitamin (0.02 to 0.04 m,ug In testing a series of 2-alkyl substituted 5,6-dimethylbenzimidazoles with L.
lactis, it was noted that the toxicity of these analogs varied directly with the length of the alkyl side chain (table 3) . While 520 ,ug per ml of the more soluble 5,6-dimethylbenzimidazole were required for half-maximal inhibition, only onefifth this amount (110 ,ug per ml) of the less soluble 2-butyl analog was required for equivalent inhibition.
Recently, Emerson et al. (1950) have demonstrated that various substituted benzimidazoles and 1,2-dimethyl,4,5-diaminobenzene, when administered orally, possessed vitamin B12 activity for the rat. These findings, coupled with Woolley's data on the precursor nature of the diamine, would indicate that both these compounds are being converted to vitamin B12, probably by the intestinal microflora. Our data, on the other hand, might lend support to an alternative hypothesis. The relatively high toxicity of these compounds to B12-requiring 2 In the case of a vitamin Bu-requiring mutant of Escherichia coli (Davis and Mingioli, 1950 ) the dimethyldiamine proved to be nontoxic, while the dimethylbenzimidazole showed the same magnitude of toxicity as obtained with the other test organisms. The lack of toxicity of the diamine for E. coli might be explained on the basis of its rapid deamination by the organism. organisms might support a theory of function through sparing action. It is conceivable that since these compounds are toxic to B12-requiring microorganisms, such organisms are inhibited in the intestinal tract thus making more B12 available to the host. In support of such a hypothesis, it is interesting to note the correlation between the microbial and animal data. Table 4 shows that in all but one case those analogs which were active in the rat test were inhibitory to the growth of L. lactis. Because the 4,6-dimethyl analog was found to be less effective against L. lactis than 5,6-dimethylbenzimidazole, it is possible that its ineffectiveness in the animal was due to suboptimal dosage.
Since the toxicity of the diamine in our studies with vitamin B12-requiring organisms is competitively antagonized by vitamin B12, it is possible that the diamine interferes with vitamin B12 function through competition for an active group. That high levels of diamine simulate dimethylbenzimidazole toxicity might indicate the conversion of the diamine to the benzimidazole, which inhibition is irreversible with vitamin B12. The competition between diamine and vitamin B12 could conceivably be for a biologically active one carbon compound, possibly "active formate." If sufficient "formate" were bound by the diamine, the concentration of the corresponding benzimidazole formed would reach the inhibitory level and the inhibition of the diamine would no longer be reversed by vitamin B12. Such a hypothesis is supported in part by the fact that the toxic level of the diamine which is irreversible by vitamin B12 is equal on a molar basis to the inhibitory concentration of the benzimidazole. However, attempts to substantiate this hypothesis by adding formate or formaldehyde to diamine inhibited cells proved negative. In addition, ultraviolet adsorption studies on diamine containing broths showed that no significant quantities of the corresponding benzimidazole were present. The elucidation of the role of vitamin B12 in neutralizing the dimethyldiamine toxicity will have to await further experimentation.
SUMMARY
Vitamin B12-requiring microorganisms are inhibited by 1,2-dimethyl,4,5-diaminobenzene, 5,6-dimethylbenzimidazole, and several substituted benzimidazoles. The toxicity of the diamine is competitively antagonized by vitamin B12 in studies with Lactobacillus lactis. Such is not the case with the 5,6-dimethylbenzimidazole and its analogs.
When suboptimal levels of vitamin B12 are supplied to L. lactis, several substituted anilines are capable of supporting optimal growth of this organism. This effect does not appear to be due to microbial synthesis of vitamin B12.
